Anti-VEGF therapy through intravitreal injections is an established treatment for reducing VEGF levels in the retina to prevent neovascularization and hard exudates in diabetic macular edema associated with vision loss in DR 9-14. This evidence concerns the gene VEGFA and diabetic macular edema.